CY1113822T1 - Χρηση χιτοσινων για την θεραπεια των φλεγμονωδων νοσων των ονυχων - Google Patents

Χρηση χιτοσινων για την θεραπεια των φλεγμονωδων νοσων των ονυχων

Info

Publication number
CY1113822T1
CY1113822T1 CY20131100040T CY131100040T CY1113822T1 CY 1113822 T1 CY1113822 T1 CY 1113822T1 CY 20131100040 T CY20131100040 T CY 20131100040T CY 131100040 T CY131100040 T CY 131100040T CY 1113822 T1 CY1113822 T1 CY 1113822T1
Authority
CY
Cyprus
Prior art keywords
chitosine
chitosin
online
treatment
inflammatory diseases
Prior art date
Application number
CY20131100040T
Other languages
English (en)
Inventor
Federico Mailland
Original Assignee
Polichem S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38212471&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1113822(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem S.A. filed Critical Polichem S.A.
Publication of CY1113822T1 publication Critical patent/CY1113822T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Σκευάσματα για νύχια βασιζόμενα σε χιτοσίνη είναι χρήσιμα για την θεραπεία φλεγμονωδών νόσων των ονύχων όπως ψωρίασης, ατοπικής δερματίτιδας και ομαλού λειχήνα. Η χιτοσίνη είναι συνήθως στην μορφή ενός αμινο-πολυσακχαριτικού παραγώγου, κατά προτίμηση υδατοδιαλυτού, όπως είναι η υδροξυπροπυλ χιτοσίνη. Το σκεύασμα μπορεί να είναι ένα βερνίκι νυχιών, ένα εκνέφωμα, μία κρέμα, μία αλοιφή, μία γέλη, μία λοσιόν ή ένας αφρός και μπορεί να έχει περιεκτικότητα σε χιτοσίνη, παράγωγο χιτοσίνης ή ένα άλας αυτού από 0,1 έως 25% κβ., σε σχέση με το συνολικό βάρος του σκευάσματος.
CY20131100040T 2007-02-14 2013-01-14 Χρηση χιτοσινων για την θεραπεια των φλεγμονωδων νοσων των ονυχων CY1113822T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07102338A EP1958639A1 (en) 2007-02-14 2007-02-14 Use of chitosans for the treatment of nail inflammatory diseases
EP08735410A EP2117565B1 (en) 2007-02-14 2008-02-07 Use of chitosans for the treatment of nail inflammatory diseases

Publications (1)

Publication Number Publication Date
CY1113822T1 true CY1113822T1 (el) 2016-07-27

Family

ID=38212471

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100040T CY1113822T1 (el) 2007-02-14 2013-01-14 Χρηση χιτοσινων για την θεραπεια των φλεγμονωδων νοσων των ονυχων

Country Status (31)

Country Link
US (1) US8906881B2 (el)
EP (3) EP1958639A1 (el)
JP (3) JP2010518139A (el)
KR (1) KR101468479B1 (el)
CN (1) CN101641103B (el)
AR (1) AR065317A1 (el)
AU (1) AU2008214695B2 (el)
BR (1) BRPI0807596A2 (el)
CA (1) CA2676259C (el)
CL (1) CL2008000443A1 (el)
CO (1) CO6210818A2 (el)
CY (1) CY1113822T1 (el)
DK (1) DK2117565T3 (el)
EA (1) EA019539B1 (el)
EC (1) ECSP099631A (el)
ES (1) ES2394169T3 (el)
HK (1) HK1132919A1 (el)
HR (1) HRP20120915T1 (el)
IL (1) IL200091A (el)
MA (1) MA31237B1 (el)
ME (1) ME00828B (el)
MX (1) MX2009008514A (el)
MY (1) MY150502A (el)
NZ (1) NZ578937A (el)
PL (1) PL2117565T3 (el)
PT (1) PT2117565E (el)
RS (1) RS52620B (el)
SI (1) SI2117565T1 (el)
UA (1) UA101151C2 (el)
WO (1) WO2008098871A2 (el)
ZA (1) ZA200904975B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
CA2622204C (en) 2005-09-12 2016-10-11 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same
WO2007033082A2 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (dmso)
US10201490B2 (en) * 2007-02-14 2019-02-12 Polichem Sa Use of chitosans for the treatment of nail inflammatory diseases
JP2012514644A (ja) 2009-01-08 2012-06-28 アラーガン インコーポレイテッド 爪成長の増進用シクロスポリン組成物
WO2011053874A1 (en) 2009-10-30 2011-05-05 Tandem Abela Development Group Llc Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EA033767B1 (ru) * 2014-06-10 2019-11-22 Makhbuba Nabi Kyzy Velieva Средство против выпадения волос на основе лекарственных растений
PL233616B1 (pl) 2017-08-10 2019-11-29 Podopharm Spolka Z Ograniczona Odpowiedzialnoscia Preparat do paznokci, dloni i stop oraz sposob wytwarzania tego preparatu
KR102511613B1 (ko) * 2019-09-23 2023-03-17 포항공과대학교 산학협력단 키토산을 포함하는 면역억제용 조성물 및 이의 용도

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE378109B (el) 1972-05-19 1975-08-18 Bofors Ab
DE3541305A1 (de) * 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
JPH08245401A (ja) * 1995-03-14 1996-09-24 Osamu Hatanaka 皮膚保護剤
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US7147854B2 (en) * 1997-06-23 2006-12-12 Yes Biotech Laboratories Ltd. Topical treatment of psoriasis using neutralizing antibodies to interleukin-8
JP4185173B2 (ja) 1997-08-07 2008-11-26 株式会社ノエビア 両親媒性キトサン誘導体及びこれを含有する皮膚外用剤
ATE290401T1 (de) * 1998-09-10 2005-03-15 Bioequal Ag Topisch anwendbare mittel gegen nagelpilzerkrankungen
DE19911056B9 (de) * 1999-03-12 2005-09-08 Biotec Asa Kosmetische Zubereitungen und deren Verwendung
JP2001055335A (ja) * 1999-08-18 2001-02-27 Toshio Sato アレルギー性皮膚疾患治療剤
JP2001131030A (ja) * 1999-11-08 2001-05-15 Kureha Chem Ind Co Ltd 発毛促進剤
DE10035991A1 (de) * 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
NO310176B1 (no) 2000-11-13 2001-06-05 Wadlund As Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne
KR20020048534A (ko) 2000-12-18 2002-06-24 안병로 파라핀 왁스를 유효성분으로 하는 피부 맛사지 팩제
SE0100166D0 (sv) 2001-01-22 2001-01-22 Tacton Systems Ab Configuration system
KR100457546B1 (ko) 2001-05-02 2004-11-18 주식회사 바이오프로젠 폴리프럭토오스 또는 그 유도체를 이용한 미소구 및 그제조방법
GB0126923D0 (en) 2001-11-09 2002-01-02 Procter & Gamble Chitosan compositions
SI1455802T1 (sl) * 2001-12-14 2009-06-30 Dnp Canada Inc Uporaba hitozanskih oligosaharidov
KR100470753B1 (ko) * 2003-01-09 2005-03-10 주식회사 자광 수용성 천연필름과 그의 제조방법
JP2004231604A (ja) 2003-01-31 2004-08-19 Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai 担体シートおよび徐放性製剤ならびにそれらの製法
EP1491202A1 (en) * 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
US20050112151A1 (en) 2003-11-20 2005-05-26 Horng Liou L. Skin adherent hydrogels
RU2258516C1 (ru) * 2004-01-20 2005-08-20 Государственное Образовательное Учреждение "Красноярская Государственная Медицинская Академия Министерства Здравоохранения Российской Федерации" Способ лечения красного плоского лишая
JP2005306746A (ja) 2004-04-19 2005-11-04 Jiyugaoka Clinic 顔面用シワ治療剤
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
JP4804770B2 (ja) * 2005-02-28 2011-11-02 株式会社アリミノ ヘアーコンディショニング剤およびその使用方法
EP1874320A1 (en) * 2005-04-19 2008-01-09 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
JP5632125B2 (ja) * 2005-06-14 2014-11-26 ジェニス イーエイチエフ．Ｇｅｎｉｓ ｅｈｆ． 部分的脱アセチル化キチン誘導体の組成物
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
EP1842545A1 (en) * 2006-04-04 2007-10-10 Marinomed Biotechnologie GmbH Anti-inflammatory polymer
DE102006049585A1 (de) * 2006-10-22 2008-04-24 Susilo, Rudy, Dr. Nagellack für kosmetische und medizinische Anwendungen

Also Published As

Publication number Publication date
EP2117565A2 (en) 2009-11-18
ECSP099631A (es) 2009-12-28
PT2117565E (pt) 2013-01-07
CA2676259C (en) 2015-07-14
MY150502A (en) 2014-01-30
ES2394169T3 (es) 2013-01-23
CN101641103A (zh) 2010-02-03
ME00828B (me) 2012-03-20
CA2676259A1 (en) 2008-08-21
EP2455086A1 (en) 2012-05-23
UA101151C2 (ru) 2013-03-11
MA31237B1 (fr) 2010-03-01
PL2117565T3 (pl) 2013-03-29
SI2117565T1 (sl) 2013-01-31
EP1958639A1 (en) 2008-08-20
EP2117565B1 (en) 2012-10-17
JP2014208709A (ja) 2014-11-06
CN101641103B (zh) 2013-05-15
CL2008000443A1 (es) 2008-08-22
AU2008214695B2 (en) 2013-10-03
KR101468479B1 (ko) 2014-12-05
AU2008214695A1 (en) 2008-08-21
NZ578937A (en) 2012-05-25
AU2008214695A2 (en) 2009-09-03
CO6210818A2 (es) 2010-10-20
ZA200904975B (en) 2010-09-29
JP6035292B2 (ja) 2016-11-30
IL200091A0 (en) 2010-04-15
DK2117565T3 (da) 2012-11-19
KR20090121302A (ko) 2009-11-25
EA200901113A1 (ru) 2010-02-26
RS52620B (en) 2013-06-28
IL200091A (en) 2013-05-30
MX2009008514A (es) 2009-08-20
EA019539B1 (ru) 2014-04-30
JP2016188252A (ja) 2016-11-04
HK1132919A1 (en) 2010-03-12
US8906881B2 (en) 2014-12-09
BRPI0807596A2 (pt) 2014-07-22
JP2010518139A (ja) 2010-05-27
WO2008098871A3 (en) 2008-10-09
US20100104670A1 (en) 2010-04-29
AR065317A1 (es) 2009-05-27
HRP20120915T1 (hr) 2012-12-31
WO2008098871A2 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
CY1113822T1 (el) Χρηση χιτοσινων για την θεραπεια των φλεγμονωδων νοσων των ονυχων
NO20074981L (no) Sammensetninger og fremgangsmater for topisk paforing og transdermal avlevering av et oligopeptid.
WO2006003290A3 (fr) Derives depolymerises sulfates d&#39;exopolysaccharides (eps) preparation et utilisations
NO20100301L (no) Forbedrete brimonidinsammensetninger for behandling av erytem
EA200971107A1 (ru) Катехоламиновые производные, полезные для лечения болезни паркинсона
EA200900211A1 (ru) Замещенные производные имидазолона, их получение и применение
RU2016146372A (ru) Комбинация гиалуроновой кислоты и сульфатированного полисахарида
AR069508A1 (es) Derivados de quinolina 057; un proceso para su preparacion; una composicion farmaceutica; la preparacion de esta y el uso del compuesto para preparar un medicamento
JP2017514825A5 (el)
PH12019502874A1 (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
ZA202202376B (en) Difluorohaloallylamine sulfone derivative inhibitors of lysyl oxidases, methods of preparation, and uses thereof
DE602005010392D1 (de) Methode zur herstellung von pilzglucan-hydrogels mit antibakterieller und immunstimulierender wirkung, sowie dessen verwendung
JP2018526458A (ja) スキンケア組成物
ES2765001T3 (es) Derivados silílicos de polisacáridos
CY1119579T1 (el) Μεθοδος για τη θεραπεια διαταραχων αναπτυξης της τριχας, οπως η γυναικειου τυπου αλωπεκια και συνεπως χρησιμα σκευασματα
WO2018118448A1 (en) Compositions containing hyaluronic acid and synergistic anti-hyaluronidase actives
CY1124899T1 (el) Μια συνεργιστικη συνθεση ως ενας προωθητης αυτοφαγιας
MA31505B1 (fr) Hydrogel de carboxyalkylamide de chitosan, sa preparation et son utilisation cosmetique et dermatologique
WO2010031248A8 (zh) 噻唑鎓盐类化合物及其治疗蛋白老化相关疾病的用途
ATE546137T1 (de) Pharmazeutische zusammensetzungen zur behandlung von warzen
TWM643368U (zh) 具有交聯聚合物結合雙層胜肽載體（dpls）之包覆結構
CY1117513T1 (el) Παραγωγα υδαντοïνης ως αναστολεις κυτταρικης νεκρωσης
US20110076338A1 (en) Composition for Skin Protection and Methods of Making Same
PL428221A1 (pl) Preparat przyspieszający proces gojenia się ran
TH181139A (th) ผลิตภัณฑ์โปรตีนกาวจากหอยแมลงภู่ และการประยุกต์ใช้ผลิตภัณฑ์นั้น ในการยับยั้งการอักเสบของผิวหนัง